FOR IMMEDIATE RELEASE

Preeclampsia Research Update: Advancements to Earlier Detection

Mountainside, NJ (April 30, 2012) -- DRG International PLFG Elisa Kits are at the forefront of Preeclampsia research. Preeclampsia affects more than one million women all over the world each year and is the leading cause of premature birth. This condition can pose great risk to both mother and child, and researchers have been exploring ways of detecting this condition, and risk factors for it, earlier in expectant mothers. DRG International’s kits are used extensively by researchers in this field, continuing our commitment to aiding in the development cutting edge diagnostic practices. Below, please find recent journal articles on Preeclampsia that our research team in Marburg, Germany has found particularly thought provoking.

Serum Concentrations of Soluble Flt-1 Are Decreased among Women with a Viable Fetus and No Symptoms of Miscarriage Destined for Pregnancy Loss

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate

Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening